Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.19.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total
Balances at beginning at Mar. 31, 2017 $ 500 $ 1,200 $ 2,300 $ 9,000 $ 146,569,600 $ (3,968,100) $ (141,998,700) $ 615,800
Balances at beginning (in shares) at Mar. 31, 2017 500,000 1,160,240 2,318,012 8,974,386        
Proceeds from sale of common stock and warrants for cash in September 2017 Public Offering, net of underwriting discount and expenses       $ 1,400 2,023,000     2,024,400
Proceeds from sale of common stock and warrants for cash in September 2017 Public Offering, net of underwriting discount and expenses (in shares)       1,371,430        
Proceeds from sale of common stock and warrants for cash in December 2017 Public Offering, net of underwriting discount and expenses       $ 10,000 13,614,000     13,624,000
Proceeds from sale of common stock and warrants for cash in December 2017 Public Offering, net of underwriting discount and expenses (in shares)       10,000,000        
Stock-based compensation expense         2,344,100     2,344,100
Accrued dividends on Series B Preferred stock         (1,030,400)     (1,030,400)
Proceeds from sale of common stock and warrants for cash in private placement offerings       $ 600 1,072,600     1,073,200
Proceeds from sale of common stock and warrants for cash in private placement offerings (in shares)       616,323        
Proceeds from exercise of warrants       $ 500       $ 0
Proceeds from exercise of warrants (in shares)       503,641        
Proceeds from exercise of stock options (in shares)               0
Fair value of common stock and warrants issued for services       $ 1,100 1,732,100     $ 1,733,200
Fair value of common stock and warrants issued for services (in shares)       1,102,500        
Fair value of common stock granted in settlement of accounts payable       $ 500 584,500     585,000
Fair value of common stock granted in settlement of accounts payable (in shares)       500,000        
Increase in fair value attributable to warrant modifications         292,700     292,700
Deemed dividend from trigger of down round provision feature         199,200   (199,200)  
Net loss             (14,345,900) (14,345,900)
Balances at end at Mar. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 23,100 167,401,400 (3,968,100) (156,543,800) 6,916,600
Balances at end (in shares) at Mar. 31, 2018 500,000 1,160,240 2,318,012 23,068,280        
Proceeds from sale of common stock for cash in February 2019 Public Offering, net of underwriting discount and expenses       $ 11,500 10,376,900     10,388,400
Proceeds from sale of common stock for cash in February 2019 Public Offering, net of underwriting discount and expenses (in shares)       11,500,000        
Stock-based compensation expense         3,443,400     3,443,400
Accrued dividends on Series B Preferred stock         (1,139,900)     (1,139,900)
Proceeds from sale of common stock and warrants for cash in private placement offerings       $ 5,000 6,626,400     6,631,400
Proceeds from sale of common stock and warrants for cash in private placement offerings (in shares)       5,025,939        
Proceeds from exercise of warrants       $ 400 605,300     605,700
Proceeds from exercise of warrants (in shares)       403,800        
Proceeds from exercise of stock options         43,900     $ 43,900
Proceeds from exercise of stock options (in shares)       29,250       29,250
Fair value of common stock issued for PH94B license and PH10 option and license       $ 2,600 4,247,400     $ 4,250,000
Fair value of common stock issued for PH94B license and PH10 option and license (in shares)       2,556,361        
Fair value of common stock and warrants issued for services       $ 200 499,300     499,500
Fair value of common stock and warrants issued for services (in shares)       175,000        
Increase in fair value attributable to warrant modifications         25,800     25,800
Net loss             (24,589,600) (24,589,600)
Balances at end at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 $ 192,129,900 $ (3,968,100) $ (181,133,400) $ 7,075,200
Balances at end (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012 42,758,630